Health Historical Income Statement
| HCAT Stock | USD 6.95 0.08 1.14% |
Historical analysis of Health Catalyst income statement accounts such as Interest Income of 17.2 M or Discontinued Operations of 0.0 can show how well Health Catalyst performed in making a profits. Evaluating Health Catalyst income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Health Catalyst's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Health Catalyst latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Health Catalyst is a good buy for the upcoming year.
Health |
About Health Income Statement Analysis
Health Catalyst Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Health Catalyst shareholders. The income statement also shows Health investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Health Catalyst Income Statement Chart
Health Catalyst Income Statement is one of the three primary financial statements used for reporting Health's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Health Catalyst revenue and expense. Health Catalyst Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Health Catalyst's Tax Provision is comparatively stable compared to the past year. Net Interest Income is likely to gain to about 9.6 M in 2024, whereas Selling General Administrative is likely to drop slightly above 55.4 M in 2024. Add Fundamental
Total Revenue
Total revenue comprises all receipts Health Catalyst generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Health Catalyst minus its cost of goods sold. It is profit before Health Catalyst operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Most accounts from Health Catalyst's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Health Catalyst current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Health Catalyst. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Health Stock please use our How to Invest in Health Catalyst guide.At this time, Health Catalyst's Tax Provision is comparatively stable compared to the past year. Net Interest Income is likely to gain to about 9.6 M in 2024, whereas Selling General Administrative is likely to drop slightly above 55.4 M in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 16.5M | 1.7M | 7.3M | 7.0M | Depreciation And Amortization | 37.5M | 48.3M | 45.2M | 27.1M |
Health Catalyst income statement Correlations
Click cells to compare fundamentals
Health Catalyst Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Health Catalyst income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Tax Provision | 142K | (1.2M) | (6.9M) | (4.3M) | 356K | 373.8K | |
| Net Interest Income | (3.5M) | (11.6M) | (16.5M) | (1.6M) | 9.1M | 9.6M | |
| Interest Income | 2.8M | 2.1M | 831K | 5.7M | 16.4M | 17.2M | |
| Depreciation And Amortization | 9.2M | 18.7M | 37.5M | 48.3M | 45.2M | 27.1M | |
| Interest Expense | 3.4M | 11.6M | 16.5M | 1.7M | 7.3M | 7.0M | |
| Selling General Administrative | 31.7M | 59.2M | 85.9M | 61.7M | 76.6M | 55.4M | |
| Selling And Marketing Expenses | 47.3M | 55.4M | 75.0M | 87.5M | 67.3M | 63.3M | |
| Total Revenue | 154.9M | 188.8M | 241.9M | 276.2M | 295.9M | 211.1M | |
| Gross Profit | 79.6M | 90.8M | 117.6M | 133.2M | 92.6M | 93.6M | |
| Other Operating Expenses | 209.8M | 285.0M | 385.6M | 416.2M | 381.7M | 309.5M | |
| Operating Income | (54.9M) | (96.1M) | (143.7M) | (140.0M) | (85.8M) | (90.0M) | |
| Net Income From Continuing Ops | (60.1M) | (115.0M) | (153.2M) | (137.4M) | (118.1M) | (124.1M) | |
| Ebit | (54.9M) | (96.1M) | (143.7M) | (140.0M) | (85.8M) | (90.0M) | |
| Research Development | 46.3M | 53.5M | 62.7M | 75.7M | 68.5M | 58.7M | |
| Ebitda | (45.7M) | (77.4M) | (106.1M) | (91.7M) | (40.5M) | (42.6M) | |
| Cost Of Revenue | 75.3M | 98.1M | 124.4M | 143.0M | 203.3M | 117.5M | |
| Total Operating Expenses | 134.5M | 186.9M | 261.2M | 273.2M | 178.4M | 192.0M | |
| Reconciled Depreciation | 9.2M | 18.7M | 37.5M | 48.3M | 42.2M | 26.6M | |
| Income Before Tax | (60.0M) | (116.2M) | (160.1M) | (141.7M) | (117.8M) | (123.7M) | |
| Total Other Income Expense Net | (5.1M) | (20.1M) | (16.5M) | (1.7M) | (32.0M) | (30.4M) | |
| Net Income Applicable To Common Shares | (240.9M) | (115.0M) | (153.2M) | (137.4M) | (123.7M) | (129.8M) | |
| Net Income | (60.1M) | (115.0M) | (153.2M) | (137.4M) | (118.1M) | (124.1M) | |
| Income Tax Expense | 142K | (1.2M) | (6.9M) | (4.3M) | 356K | 373.8K |
Pair Trading with Health Catalyst
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Health Catalyst position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Health Catalyst will appreciate offsetting losses from the drop in the long position's value.Moving together with Health Stock
| 0.71 | DH | Definitive Healthcare | PairCorr |
| 0.82 | LH | Laboratory | PairCorr |
Moving against Health Stock
| 0.52 | CI | Cigna Corp Sell-off Trend | PairCorr |
| 0.5 | DXCM | DexCom Inc | PairCorr |
The ability to find closely correlated positions to Health Catalyst could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Health Catalyst when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Health Catalyst - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Health Catalyst to buy it.
The correlation of Health Catalyst is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Health Catalyst moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Health Catalyst moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Health Catalyst can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Health Catalyst. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Health Stock please use our How to Invest in Health Catalyst guide.Note that the Health Catalyst information on this page should be used as a complementary analysis to other Health Catalyst's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for Health Stock analysis
When running Health Catalyst's price analysis, check to measure Health Catalyst's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health Catalyst is operating at the current time. Most of Health Catalyst's value examination focuses on studying past and present price action to predict the probability of Health Catalyst's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health Catalyst's price. Additionally, you may evaluate how the addition of Health Catalyst to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |
Is Health Catalyst's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Health Catalyst. If investors know Health will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Health Catalyst listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.84) | Revenue Per Share 5.189 | Quarterly Revenue Growth 0.012 | Return On Assets (0.07) | Return On Equity (0.28) |
The market value of Health Catalyst is measured differently than its book value, which is the value of Health that is recorded on the company's balance sheet. Investors also form their own opinion of Health Catalyst's value that differs from its market value or its book value, called intrinsic value, which is Health Catalyst's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Health Catalyst's market value can be influenced by many factors that don't directly affect Health Catalyst's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Health Catalyst's value and its price as these two are different measures arrived at by different means. Investors typically determine if Health Catalyst is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Health Catalyst's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.